Sydney West Retina

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Macular degeneration6 trials
• Diabetic eye disease3 trials

Phase

• Phase 24 trials
• Phase 11 trial
• Phase 1/21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Not yet recruiting2 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• Janssen Research & Development, LLC2 trials
• Filamon LTD1 trial
• Kiora Pharmaceuticals, Inc.1 trial
• Sitala Bio LTD1 trial
• and 2 more

Running trials

• Recruiting

  A Study in Adults With Geographic Atrophy

  NCT07606365· Phase 2· Sitala Bio LTD· Source

  Contact: Clinical Operations Manager

• Not yet recruiting

  First in Human Study of BETA-TT8 in wetAge-related Macular Degeneration (wetAMD)

  NCT07766473· Phase 1/2· Filamon LTD· Source

  Contact: Paul Mitchell, MBBS (hons) MD PhD FRANZCO

• Recruiting

  Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

  NCT06825702· Phase 2· Kiora Pharmaceuticals, Inc.· Source

  Contact: Honey Grace Paule

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

  NCT06770933· Phase 2· Vantage Biosciences Ltd· Source

• Recruiting

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· Phase 2/3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

  NCT05476926· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration3 recruiting

Closed trials

• Recruiting

  A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.

  NCT06701721· Phase 1· Therini Bio Pty Ltd· Source

  Contact: Liza Wallace

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Hoffmann-La Roche· Source